Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT

NCT03385096 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

122

Enrollment

OTHER

Sponsor class

Conditions

Autologous Hematopoietic Stem Cell Transplantation
Conditioning
Multiple Myeloma

Interventions

DRUG: Busulfan (BU)
DRUG: Cyclophosphamide (CY)
DRUG: Etoposide (VP-16)
DRUG: Melphalan

Sponsor

Nanfang Hospital, Southern Medical University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]